Skip to content
Menu

Enanta Pharma Q4 EPS $(0.81) Misses $(0.78) Estimate, Sales $12.868M Miss $14.200M Estimate

Benzinga Newsdesk 13 hours ago

NewsEarningsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.78) by 3.85 percent. This is a 6.9 percent increase over losses of $(0.87) per share from the

Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.78) by 3.85 percent. This is a 6.9 percent increase over losses of $(0.87) per share from the same period last year. The company reported quarterly sales of $12.868 million which missed the analyst consensus estimate of $14.200 million by 9.38 percent. This is a 14.92 percent decrease over sales of $15.125 million the same period last year.

Read at benzinga.com